Concepedia

Jiang Shi

JS

Statistics

Publications

17

Citations

974

H-Index

16

Active since

2019

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Sir Run Run Shaw Hospital

Zhejiang University

Zhejiang Cancer Hospital

Zhejiang Lab

Jiang Shi is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2019–2024

17

Publications

17

N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling

Junjie Xu, Zhe Wan, Minyue Tang et al. · Molecular Cancer · 2020 · 320 citations · Full text

, , +17

Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma

Jiang Chen, Tong Ji, Di Wu et al. · Cell Death and Disease · 2019 · 96 citations · Full text

, , +17

miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR

Lin Ji, Zhongjie Lin, Zhe Wan et al. · Cell Death and Disease · 2020 · 90 citations · Full text

, , +17

LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription

Zhongjie Lin, Shunjie Xia, Yuelong Liang et al. · Theranostics · 2020 · 63 citations · Full text

, , +17

N-Acetyltransferase 10 Enhances Doxorubicin Resistance in Human Hepatocellular Carcinoma Cell Lines by Promoting the Epithelial-to-Mesenchymal Transition

Xiuming Zhang, Chen Jiang, Jiang Shi et al. · Oxidative Medicine and Cellular Longevity · 2019 · 61 citations · Full text

, , +17

1–5 of 17